Peripheral blood lymphocytes from t3 patients with established insulin-dependent diabetes mellitus (IDDM) and 2 prediabetic patients were examined for natural killer (NK) and antibody-dependent cellular cytotoxic activities (ADCC), lectin-dependent cellular cytotoxicity (LDCC), interferon-and interleukin-2-induced cytotoxicity, and concanavalin A-induced suppressor-cell activities in comparison with age-matched normal controls. IDDM patients demonstrated normal levels of NK and ADCC activities against K562 and antibody-coated SB target cells, respectively, compared to controls. IDDM patients showed normal levels of LDCC activity. Notable deviations from control values were, however, observed with diabetic lymphocytes in the following systems. Interferon-and interleukin-2-induced NK activities were significantly higher with IDDM lymphocytes than with control cells. IDDM lymphocytes precultured with concanavalin A demonstrated lower NK and ADCC activities than control cells and manifested decreased suppressor effects on the NK activity of normal allogeneic lymphocytes. Lymphocytes from one of two prediabetic patients showed increased NK, ADCC, and LDCC activities in comparison to controls. The increased interferon-and interleukin-2-induced enhancement of NK activity and reduced suppressor activity of lymphocytes from IDDM patients may be involved in the pathogenesis of the disease.
INTRODUCTION
Recent evidence has suggested a role for autoimmune mechanisms in the pathogenesis of insulindependent diabetes mellitus (IDDM). Support for this premise derives from several observations made in diabetic patients. Lymphocytic infiltration of pancreatic islets has been described in patients with IDDM (1) . The presence of specific islet-cell antibodies has been noted generally during the early stages of disease (2, 4) ; these antibodies may exhibit complement-dependent cytotoxicity against islet cells (3) . Increased numbers of functional T cells have been observed in the peripheral blood of IDDM patients (6) and some of these cells were "activated" T cells (5) . Specific destruction of islet cells by immune lymphocytes from diabetic patients can occur in vitro (7) , Finally, patients with IDDM can manifest delayed-and/or immediate-type hypersensitivity to insulin and pancreatic extracts (8, 9) .
Recent studies on natural killer (NK) and antibody-dependent cellular cytotoxic (ADCC) effector cells have examined their role in immunologic surveillance against tumors and in the regulation of various immune reactions (10--12) . The significance of NK and ADCC reactions and the mechanisms that control these functions have not previously been examined in patients with type I diabetes. The present studies were designed to investigate the NK and ADCC activities of lymphocytes from patients with IDDM and prediabetes in comparison with normals. Further, the immunoregulatory effects of diabetic lymphocytes precultured with and without concanavalin A (Con A) on the NK activities of lymphocytes from normal allogeneic donors were also examined. These studies demonstrate that pa-tients with type I diabetes have normal ranges of NK and ADCC activities against tumor target cells. However, compared to healthy controls, diabetic lymphocytes showed decreased Con A-inducible suppressor-cell activity on the NK functions of normal allogeneic lymphocytes.
MATERIALS AND METHODS

Patients
Thirteen white IDDM patients, six males and seven females, ranging in age from 17 to 37 years, with a disease duration of 1.5 to 23 years (mean, 13.9 years), were investigated. All patients were receiving insulin at the time of study. Twelve of the 13 patients were seronegative for cytoplasmic isletcell antibodies (ICA) as determined by immunofluorescence using fresh-frozen human blood group O pancreas as described (2) . Two white prediabetic patients, a male aged 27 years and a female aged 25 years, were also examined. The diagnosis of prediabetes was based on strongly ICA-positive sera and a normal insulin response to IVGTT in the male and an abnormal OGTT with normal fasting and postprandial blood glucose in the female.
Depletion of Adherent Cells
PBMC were suspended in RPMI 1640 with 10% FCS and depleted of adherent cells by passage through a 7-mt column of Sephadex G-10 beads (Pharmacia Fine Chemicals, Piscataway, N J), equilibrated in the same medium. After 45 rain of incubation at 37°C, nonadherent peripheral blood lymphocytes (PBL) were eluted with 1 bed vol of medium at 37°C. Cell recovery was >70% of the total input and monocyte contamination as indicated by nonspecific esterase staining was <2%.
Preparation of Target Cells
The human erythroleukemia cell line, K562, was used as targets for NK cells in a 4-hr SlCr release assay. For the ADCC assay, we chose as targets an antibody-coated human B-cell leukemia line (SB) because of its resistance to NK activity. Target cells 'passaged for 48 hr were washed twice with CM. To 0.8-ml aliquots of CM containing 5 x 10 6 tumor cells, 200 ixCi of 51Cr as sodium chromate (New England Nuclear, Boston, MA) was added. The cells were incubated at 37°C for 1 hr in a humidified atmosphere of 5% CO2 in air with intermittent shaking. Following incubation, the cells were washed three times with CM and resuspended to a concentration of 1 x 105 cells/ml.
Controls
A group of 15 age-matched, healthy, white volunteers of both sexes with no history of autoimmune disease, allergy, or diabetes was investigated for comparison.
Isolation of Lymphocytes
Peripheral blood mononuclear cells (PBMC) were isolated from heparinized (20 U/ml) venous blood using a modified method of Boyum (13) . Blood was diluted with an equal volume of normal saline and centrifuged at 400g for 30 rain at 18°C. The mononuclear-cell band was harvested, washed three times with saline, and resuspended in RPMI 1640 medium, containing 25 mM Hepes buffer supplemented with 10% heat-inactivated fetal calf serum (FCS) (GIBCO, Grand Island, NY), 80 p~g/ml gentamicin (Schering Corp., Kenilworth, N J), and 300 ~xg fresh glutamine/ml (complete medium).
Assay for NK Activity
NK activity was measured in a direct 51Cr release assay as previously described (14) . A fixed number of viable effector cells in CM was added to triplicate cultures of 51Cr-labeled targets in V-bottom microtitration plates (CoStar, Cambridge, MA). After centrifugation at 40g for 2 rain, they were incubated at 37°C in a humidified atmosphere of 5% CO2 in air for 4 hr. At the end of incubation the plates were centrifuged at 400g for 10 rain and 100-~xl aliquots were removed from each well, transferred to glass tubes, and read in a Packard Model 593 gamma counter. Percentage cytotoxicity was calculated as follows:
% cytotoxicity = experimental release -spontaneous release x 100, total release -spontaneous release where spontaneous release represents counts released from control wells containing 1 x 104 target cells, and total release represents counts obtained from an aliquot of I x 104 target cells. Cytotoxicity was also expressed as lytic units (LU) per 107 effector cells, defined as the number of effector cells needed to yield 30% cytotoxicity of 1 x 104 target cells. LU were calculated by linear regression analysis from a cytotoxicity curve using four different effector-to-target (E:T) cell ratios for each test as described by Kadish et al. (15) .
Assay for ADCC Activity
ADCC activity was determined as previously described (14) . Briefly, 50 txl of varying concentrations of effector cells was added to 50 Ixl of CM containing 51Cr-labeled SB target cells and 100 pol of a 2 x 10 -4 dilution of rabbit anti-SB antiserum previously found to yield maximum ADCC. Percentage cytotoxicity was calculated as described above for N K activity with the following exceptions. Spontaneous release represents counts released in control wells containing effector cells, 51Cr-labeled SB target cells, and medium without anti-SB antibody, and total release represents counts obtained in an aliquot of 1 x 104 labeled target cells.
Lectin-Dependent Ceil-Mediated Cytotoxicity (LDCC) Assay
The LDCC assay was carried out similarly to the NK assay except that NK-resistant SB cells were used as targets (16) . Briefly, different numbers of target and effector cells were added to V-bottom microtitration plates, followed by phytohemagglutinin-P (PHA; Difco Laboratories, Detroit, MI) at concentrations of I, 2.5, and 5 ~g/rnt to a final volume of 0.2 ml. The plates were incubated for 4 hr at 37°C in a humidified 5% CO2 in air incubator. Percentage LDCC activity was calculated as described for NK activity and was compared with cytotoxicity observed with control cultures containing effector and target cells in the absence of PHA. Percentage cytotoxicity was calculated as follows:
% cytotoxicity = experimental release -spontaneous release x 100, total release -spontaneous release where spontaneous release represents counts released from control wells containing 1 x 10 4 target cells alone plus lectin, and total release represents counts obtained in an aliquot of 1 x 10 4 target cells.
Interferon
Recombinant interferon-alpha (IFN) (specific act, -1 × 108 U/mg protein) was a gift from Schering Corp., Bloomfield, NJ. IFN was diluted in RPMI 1640 and stored at -70°C before use. The maximum N K augmenting dose was 250 U/ml as previously determined.
Interleukin-2 (IL2)
Commercially available IL2 (Electro-Nucleonics Labs, Inc., Silver Spring, MD) was diluted in RPMI 1640 and stored at -70°C before use. IL2 was purified from human peripheral blood leukocytes by several chromatographic steps and is devoid of any lectin or IFN. A final concentration of 64 U/ml, the maximal NK augmenting dose as previously determined, was used.
In Vitro Generation of Suppressor Cells with Con A
Total PBL were suspended in CM at a concentration of 4 x 10 6 cells/ml, to which Con A at a concentration of 30 jxg/ml was added. A duplicate set of cultures received CM without Con A as a control. All cultures were incubated in a humidified environment of 5% CO2 in air at 37°C for 48 hr. Cells were washed four times with saline and resuspended in CM as described (17) . Cell viability as determined by trypan blue dye exclusion was not affected by concentrations of -<30 ~xg Con A/ml and was found to be >70%. The viability was comparable with that of control cultures. Estimation of nonspecific esterase-positive cells was approximately 10.5% in control cultures and about 6.0% in Con A-treated cultures. The percentage of phagocytic cells, as identified by ingestion of latex particles, was approximately 9% in control cultures and about 4.5% in Con A-treated cultures.
Assay of Suppressor-Cell Activity
In coculture experiments to measure suppressorcelt activity, PBL precultured with or without Con A were added to a mixture of effector and prelabeled target cells. The observed cytotoxicity demonstrated by the cell mixture was compared to the sum of cytotoxicities shown by precultured PBL and effector cells when tested alone. In these mixing experiments the E:T cell ratio and suppressor-toeffector (S:E) cell ratio were maintained at 50:1 and I:1, respectively. All plates were treated as described for the cytotoxicity assay. Percentage suppression was calculated as detailed elsewhere (17) or, briefly, as follows: predicted cytotoxicityobserved cytotoxicity % suppression = x 100, predicted cytotoxicity where predicted cytotoxicity is calculated as the sum of the individual cytotoxicities of effector cells plus precultured PBL, and observed cytotoxicity is the cytotoxicity demonstrated by the mixture of effector and precultured PBL. Results are expressed as mean values -+ SE. The statistical significance of differences in mean values was determined using a single-tail Student t-test formula. Figure 1A shows the NK activity of normal, diabetic, and prediabetic lymphocytes, at different E:T cell ratios. A total of 12 IDDM and 2 prediabetic patients was compared with 12 normal controls at each E:T cell ratio. Diabetic patients manifested considerable variation in their NK activity at all E:T cell ratios. At a 50:1 E:T cell ratio, diabetic patients showed cytotoxicity ranging from 3 to 69%, with a mean of 39%, compared to a mean of 51% for normals (P < 0.2). At a 25:1 E:T cell ratio; diabetic patients demonstrated a mean of 29% NK activity, compared to 37% cytotoxicity manifested by normals (P < 0.2). At I0:1 and 5:1 E:T cell ratios, diabetic patients demonstrated a mean of 20 and 13% NK activity, respectively, compared to a mean of 19 (P < 0.2) and 12% (P < 0.2), by normals. One of two prediabetic patients demonstrated increased NK activities of 69, 60, 44, and 25% at 50:1, 25:1, 10:1, and 5:1 ET cell ratios, respectively. Figure 1B shows that 10 diabetic patients demonstrated a mean of 24, 17, 12, and 9% ADCC activity, compared to 39 (P < 0.2), 29 (P < 0.2), 23 (P < 0.2), and 10% (P < 0.1) shown by 10 normals at 50:1, 25:1, 10:1, and 5:1 E:T cell ratios, respectively. One of two prediabetic patients also showed increased ADCC activity compared to controls at all E:T cell ratios. In summary, only 2 of 11 IDDM patients manifested markedly lower levels of NK activity (3 and 12% killing), while 2 other IDDM patients demonstrated decreased levels of ADCC activity (1 and 5% killing) at 50:1 E:T cell ratios. A similar pattern of reduced NK and ADCC activities was observed at other E:T cell ratios for these two patients. These data demonstrate that NK and ADCC activities of lymphocytes from IDDM patients are comparable to those of normals.
RESULTS
NK and ADCC Activities of Lymphocytes from IDDM Patients
Lectin-Dependent Cellular Cytotoxicity of lDDM Lymphocytes
Since the majority of IDDM lymphocytes demonstrated normal levels of NK and ADCC activities, we investigated whether they could be further activated by lectin. Data presented in Table I demonstrate that normal lymphocytes produced significantly increased cytotoxicity, against nonsensitive NK targets, SB cells, at all PHA concentrations, compared to negligible cytotoxicity in the absence of PHA. Diabetic lymphocytes exhibited a cytotoxicity of 2% without PHA, which was significantly enhanced by the addition of PHA. It is interesting to note that one prediabetic patient produced 21% spontaneous cytotoxicity against the usually insensitive SB target cells, which was further enhanced with varying concentrations of PHA. The second prediabetic patient showed enhancement of cytotoxicity with PHA comparable to that of diabetic lymphocytes. These data suggest that the percentage enhancement of cytotoxicity by PHA was comparable in diabetics and controls, although a greater than normal enhancement of LDCC was demonstrated in one of two prediabetic patients.
In Vitro Effect of Glucose and Insulin on the NK Activity of Normal Lymphocytes
To investigate whether the poor gtycemic control often seen at diagnosis of IDDM patients could also influence the cytotoxic activities of their lymphocytes, PBL from normal donors preincubated for 24 hr with varying concentrations of glucose were examined for NK activity. Data presented in Table  II demonstrate that a range of glucose concentrations did not show any effect on the NK activity of normal lymphocytes. We also examined whether insulin could modulate the cytotoxic functions of normal lymphocytes (Table III) . These results dem- onstrate that lymphocytes precultured with varying concentrations of pork insulin showed a moderate enhancement of their NK activity compared to control lymphocytes. 
Effect of lFN and IL2 on NK Activity of lDDM Lymphocytes
Suppression of" NK Activity of Fresh Lymphocytes by Lymphocytes Precultured with Con A
We studied the effect of preculturing total PBMC with and without Con A to induce suppressor cells. 
"The lectin-dependent cellular cytotoxicity (LDCC) assay was carried out similarly to the NK assay except the NK-resistant SB cell line was used as targets. Effector cells were depleted of adherent cells and targets were labeled with 5~Cr. bCytotoxicity was calculated as described in Materials and Methods. Walues represent mean percentage cytotoxicity -+ SD of five separate experiments performed in triplicate at a 50: t E:T cell ratio. dData in parentheses indicate the percentage enhancement of cytotoxicity. ~Statistical values were determined by a single-tail Student's t test. SIslet-cell antibody-positive patients without overt disease. Data presented in Fig. 3 show that normal PBMC precultured with 30 Ixg Con A/ml displayed significantly lower levels of NK activity than manifested by PBMC precultured in medium alone. In contrast, PBMC from diabetic patients precultured with Con A did not exhibit any significant inhibition of cytotoxicity compared to patients' cells in the absence of Con A. The failure of Con A to reduce the cytotoxicity of patients' PBMC to levels comparable to those of healthy donors suggests a potential defect in the generation of Con A-inducible suppressor cells in IDDM. Results presented in Table  IV demonstrate that normal donor lymphocytes precultured with Con A suppressed the cytotoxicity of allogeneic normal lymphocytes. Lymphocytes from three of five diabetic patients precultured with Con A showed diminished suppression of the NK activity of fresh normal, allogeneic lymphocytes. PBL from both prediabetic patients precultured with Con A, however, showed marked inhibition of the NK activity of normal lymphocytes.
DISCUSSION
Because of the role of autoimmune mechanisms in the pathogenesis of IDDM, analysis of the immune status of diabetic patients may be of significance in understanding the disease process. Recent evidence suggests that NK and ADCC reactions are important in the regulation of various immunological reactions, in addition to their proposed role in immune surveillance against tumors and virus-infected cells (9) (10) (11) . Several studies on the immunologic activities of lymphocytes from IDDM patients have yielded conflicting results (17) (18) (19) (25) observed that 46% of newly diagnosed patients' sera supported ADCC activity against pancreatic islet cells. A marked reduction of T3, T4, T8, and M1 antigen expression on the lymphocytes of newly diagnosed IDDM patients compared to patients with long-standing disease has been reported (26) .
The results of the experiments described herein demonstrate that, in general, lymphocytes from IDDM patients express NK and ADCC activities comparable to those of matched normal controls (Figs. 1A and B) . The wide variation of NK and ADCC activities observed in diabetic patients may be associated with heterogeneity of disease including duration, genetic profile, insulin response, etc. It is interesting to note that one of two patients with prediabetes who were seropositive for ICA demonstrated increased NK and ADCC activities, suggesting that dysfunction of immune surveillance mechanisms may occur during the period preceding clinical onset of the disease.
It has been previously demonstrated that lymphocyte cytotoxicity can be activated by lectin. The exact function of lectin activation is not presently understood, but it has been suggested that it may act directly on cytotoxic cells by rearranging receptors for recognition sites on target cells or providing sufficient signals to trigger subsequent lytic events (27, 28) . In this report the percentage enhancement of LDCC in diabetic patients is similar to that in normals (Table I) . However, the increased basal cytotoxicity of lymphocytes from one prediabetic patient against SB targets, which are not sensitive to NK activity, could be a manifestation of the prodrome of IDDM. A more comprehensive assessment of immune function should be undertaken in diabetes.
Recently it has been demonstrated that insulin may be associated with immunostimulation. Helderman and Raskin (29) found a comparable number of insulin receptors on PHA-activated T cells from juvenile-onset diabetics and healthy con- Washed PBL were tested for NK activity against prelabeled K562 target cells at a 50:1 E:T cell ratir. Enhancement of NK activity by IFN or IL2 treatment of lymphocytes was calculated in comparison with untreated control lymphocytes. The statistical significance of differences was determined using a single-tail Student t test.
trois. It was also shown that insulin augments the metabolism of activated T cells in a rat model (30) .
The results reported herein demonstrate that insulin may have some stimulatory effect on the cytotoxic activity of precultured normal lymphocytes (Table  III) . Enhancement of cytotoxicity by exogenous insulin may partially explain the paradoxical observation of normal NK function by IDDM tymphocytes in spite of decreased Leu 7-and T8-positive lymphocytes as reported by others (23, 24, 26, 31) . Since T lymphocytes can also express NK-like cytotoxicity against K562 targets, this effect of insulin may be due to recruitment of functionally NK reactive cells from the T-cell population. Experiments using purified HNK1 + or Leu 7 + mono- (17) . This suppressorcell activity could be further enhanced by preculturing lymphocytes with Con A. Previous studies have shown that IDDM patients demonstrate reduced antigen-specific or nonspecific suppressor-cell activities in vitro as measured by the lymphocyte proliferative response to mitogen and alloantigens (43) (44) (45) . Although preculture of lymphocytes from IDDM patients or controls with Con A results in diminished NK activity, treated PBL from diabetics demonstrated persistently higher NK activity than controls. This observation is consistent with the premise that Con A was not as effective in inducing suppressor activity in PBL from IDDM patients as it was with normal lymphocytes. To confirm this, mixing experiments utilizing Con A-pretreated lymphocytes were undertaken. Our results indeed demonstrated a deficiency of Con A-inducible suppressor cells using lymphocytes from IDDM patients. Because of the increasing evidence that cytotoxic cells may be involved in the destruction of pancreatic beta cells, an analysis of the interplay between activated suppressor cells and NK cells may further elucidate the immunopathogenesis of IDDM. Diminished suppressor-cell functions associated with IDDM may explain, in part, the escape of cytotoxic activities from normal immunoregulatory mechanisms resulting in islet-cell destruction. The paradoxical observation of increased NK activity associated with the prediabetic state may be a manifestation of normal immunologic antiviral surveillance, especially if one considers a possible viral etiology for IDDM. Thus suppressor-cell activation might counteract progressive destruction of uninfected islet cells after elimination of any putative initial infection. Failure of suppressor-cell activation could ultimately result in total islet-cell destruction and IDDM, Moreover, cytotoxicity may be further stimulated by an increased sensitivity to IFN and IL2 as our data suggest.
The studies reported herein using tumor-cell targets are our initial investigations examining cytotoxic activities in IDDM. Further experiments using pancreatic islet-cell targets will attempt to address the specificity of these observations. In summary, however, it appears that IDDM may be associated with an increased sensitivity of cytotoxic cells to enhancement with IFN and IL2 and decreased suppressor-cell activity. These immunologic mechanisms may play a role in the pathogenesis of the disease.
